NEW YORK, Dec 14 (Reuters) - Guidant Corp (GDT.N: Quote, Profile, Research) has filed reports with the U.S. Food and Drug Administration about three new deaths associated with short circuits in its heart devices, the New York Times reported on Wednesday.
